Galecto Inc (GLTO)

Apr 16, 2025

Keppel DC REIT (OTCMKTS:KPDCF) Short Interest Up 133.4% in March - Defense World

Apr 16, 2025

Apr 16, 2025

Galecto, Inc. (NASDAQ:GLTO) Short Interest Up 133.6% in March - Defense World

Apr 16, 2025

Apr 11, 2025

Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - benzinga.com

Apr 11, 2025

Apr 03, 2025

Galecto, Inc. Focuses on Oncology and Liver Diseases - TipRanks

Apr 03, 2025

Apr 03, 2025

GLTO stock touches 52-week low at $2.78 amid sharp annual decline - Investing.com UK

Apr 03, 2025

Mar 27, 2025

Galecto stock hits 52-week low at $3.75 amid market challenges - Investing.com

Mar 27, 2025

Mar 27, 2025

Galecto stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 26, 2025

Galecto stock hits 52-week low at $4.39 amid market challenges - MSN

Mar 26, 2025

Mar 26, 2025

Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews

Mar 26, 2025

Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 25, 2025

Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025

Mar 21, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 21, 2025

Mar 21, 2025

Galecto (GLTO) Shares Rally Amid Positive Market Momentum - Stocks Telegraph

Mar 21, 2025

Mar 20, 2025

Galecto Reports Full-Year 2024 Financial Results - The Manila Times

Mar 20, 2025

Mar 19, 2025

Galecto Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025

Mar 19, 2025

Galecto, Inc. Completes Strategic Review, Acquires Global Rights to GB3226 for Oncology and Liver Disease Focus - Nasdaq

Mar 19, 2025

Mar 19, 2025

Galecto Cuts Losses by $17M, Acquires Promising AML Drug Candidate - StockTitan

Mar 19, 2025

Mar 19, 2025

Galecto Inc expected to post a loss of $2.97 a shareEarnings Preview - TradingView

Mar 19, 2025

Mar 14, 2025

Idiopathic Pulmonary Fibrosis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approvals, Therapies, Mechanism of Action, Route of Administration & Companies by DelveInsight - The Globe and Mail

Mar 14, 2025

Mar 12, 2025

Galecto stock plunges to 52-week low at $3.76 amid market challenges - Investing.com Australia

Mar 12, 2025

Mar 11, 2025

Galecto stock plunges to 52-week low at $3.76 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 07, 2025

Galecto (GLTO) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 07, 2025

Mar 06, 2025

Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga

Mar 06, 2025

Feb 28, 2025

Galecto stock hits 52-week low at $4.20 amid market challenges - Investing.com Australia

Feb 28, 2025

Feb 27, 2025

Galecto stock hits 52-week low at $4.20 amid market challenges By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 15, 2025

Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World

Feb 15, 2025

Feb 12, 2025

Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World

Feb 12, 2025

Feb 11, 2025

Galecto to Participate in Upcoming Investor Conferences - The Globe and Mail

Feb 11, 2025

Feb 11, 2025

Galecto stock hits 52-week low at $4.39 amid market challenges By Investing.com - Investing.com South Africa

Feb 11, 2025

Feb 11, 2025

Leerink Partnrs Estimates Galecto FY2024 Earnings - Defense World

Feb 11, 2025

Feb 08, 2025

Brokers Set Expectations for Galecto FY2029 Earnings - Armenian Reporter

Feb 08, 2025

Feb 06, 2025

Galecto to Participate in Upcoming Investor Conferences -February 06, 2025 at 08:01 am EST - Marketscreener.com

Feb 06, 2025

Feb 06, 2025

Biotech Spotlight: Galecto Lines Up Triple Conference Showcase for Investors - StockTitan

Feb 06, 2025

Feb 01, 2025

Where are the Opportunities in (GLTO) - Stock Traders Daily

Feb 01, 2025

Jan 24, 2025

Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga

Jan 24, 2025

Jan 23, 2025

Critical Analysis: Galecto (NASDAQ:GLTO) vs. ObsEva (NASDAQ:OBSV) - Defense World

Jan 23, 2025

Jan 22, 2025

(GLTO) On The My Stocks Page - Stock Traders Daily

Jan 22, 2025

Jan 13, 2025

Analyzing Galecto (NASDAQ:GLTO) and Pasithea Therapeutics (NASDAQ:KTTA) - Defense World

Jan 13, 2025

Jan 09, 2025

After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win - PharmaVoice

Jan 09, 2025

Jan 07, 2025

Galecto CEO Hans T. Schambye sells $7,509 in shares - Investing.com

Jan 07, 2025